Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
A Better Way to Classify Young Women’s Heart Attacks
A new study, sponsored by Women’s Health Research at Yale, shows how a sex-specific classification system can define and group types of heart attacks that are more common for women. In doing so, the researchers have produced a more accurate guide to treatment and prognosis.
Opioid epidemic responses overlook gender
In a commentary published in The Lancet, Women’s Health Research at Yale Director Carolyn M. Mazure, and Yale Program in Addiction Medicine Director David A. Fiellin, M.D., called for researchers, clinicians, and policymakers to account for the different ways in which women encounter opioid addiction and treatment.
Many Women in Low-Income Areas Have Poor Access to Obstetric and Neonatal Care, Study Finds
A research team led by the Yale School of Public Health has found that many pregnant women in low-income areas have to travel farther than their peers to reach the nearest hospitals to deliver their babies-and the gap in accessible health care appears to be growing.
Opportunities to vaccinate young women against HPV missed at alarming rate
en aged 18-26 who were eligible to receive Human Papilloma Virus (HPV) vaccine have missed at least one opportunity to receive the vaccine during a visit to an obstetrics and gynecology clinic, Yale researchers report. This study also confirms previous research showing racial disparities in vaccination for HPV: Women who identify as black are 61% more likely have had a missed opportunity than women who identify as white. These findings are published in the American Journal of Obstetrics and Gynecology. HPV is a well-known cause of pre-cancerous cervical lesions, which, if untreated, could develop into cervical cancer. Immunization against HPV has been shown to be safe and effective in preventing these pre-cancerous lesions. The two-dose HPV vaccine is recommended for administration to It is recommended that girls ages 11-12 receive the two-dose HPV vaccine, and that those through age 26 receive the three-dose vaccination for “catch-up.”
Shedding Light on the Relationship of Depression, Stress, and Families
Research on depression has come a long way since 1978, a topic that Dr. Constance Hammen discussed with an engaged audience at a Grand Rounds presentation in May sponsored by the Women’s Behavioral Health Division of Yale School of Medicine’s Department of Psychiatry.
Medical devices often approved for use without testing for safety by sex and gender
A new study finds that before the government approves medical devices for use on the public, companies applying for approval rarely determine if or how sex and gender might influence their safety or effectiveness.
Acupuncture, Widely Used, Found to be Ineffective in Improving Live Birth Rate
In a surprising finding, a collaboration between the researchers in China, the United States and Europe reveals that acupuncture is ineffective in improving live birth rate in women with Polycystic Ovarian Syndrome, or PCOS, contrary to prevailing wisdom and common practice.
Women’s Health Research at Yale funds studies on colon cancer, infections in pregnancy, and domestic violence
“Through our competitive peer review process, these three studies stood out as extremely promising opportunities to improve and even save lives,” said Dr. Carolyn M. Mazure, director of WHRY. “With these new grants, we continue to expand a broad scope of existing work to focus on questions vital to the health and well-being of millions of women, men, and children.”